Quest for the Cure: Testing the Old and New to Prevent Progression of Autosomal Dominant Polycystic Kidney Disease.
作者信息
Brosnahan Godela
机构信息
University of Colorado Denver, Anschutz Medical Campus, Aurora, CO.
出版信息
Kidney Med. 2019 Oct 31;1(6):329-331. doi: 10.1016/j.xkme.2019.10.004. eCollection 2019 Nov-Dec.
Abstract
摘要
相似文献
1
Quest for the Cure: Testing the Old and New to Prevent Progression of Autosomal Dominant Polycystic Kidney Disease.寻求治愈方法：新旧方法测试以预防常染色体显性多囊肾病的进展
Kidney Med. 2019 Oct 31;1(6):329-331. doi: 10.1016/j.xkme.2019.10.004. eCollection 2019 Nov-Dec.
2
Renin-Angiotensin-aldosterone system in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中的肾素-血管紧张素-醛固酮系统
Curr Hypertens Rev. 2013 Feb;9(1):12-20. doi: 10.2174/1573402111309010003.
3
Predictors of autosomal dominant polycystic kidney disease progression.常染色体显性多囊肾病进展的预测因素。
J Am Soc Nephrol. 2014 Nov;25(11):2399-418. doi: 10.1681/ASN.2013111184. Epub 2014 Jun 12.
4
RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.RAPID-ADPKD（亚太地区常染色体显性遗传性多囊肾病快速进展患者的回顾性流行病学研究）：一项多中心、回顾性队列研究的研究方案。
BMJ Open. 2020 Feb 6;10(2):e034103. doi: 10.1136/bmjopen-2019-034103.
5
Changing referral characteristics of patients with autosomal dominant polycystic kidney disease.常染色体显性遗传多囊肾病患者转诊特征的变化。
Am J Med. 2013 Sep;126(9):832.e7-832.e11. doi: 10.1016/j.amjmed.2012.12.018. Epub 2013 Jul 3.
6
Autosomal dominant polycystic kidney disease with diffuse proliferative glomerulonephritis - an unusual association: a case report and review of the literature.常染色体显性多囊肾病合并弥漫性增生性肾小球肾炎——一种不寻常的关联：一例病例报告及文献复习
J Med Case Rep. 2010 Apr 29;4:125. doi: 10.1186/1752-1947-4-125.
7
[Cardiovascular disorders in autosomal dominant polycystic kidney disease].[常染色体显性多囊肾病中的心血管疾病]
Nephrol Ther. 2021 Feb;17(1):18-29. doi: 10.1016/j.nephro.2020.09.003. Epub 2021 Jan 8.
8
A quest--halting the progression of autosomal dominant polycystic kidney disease.一项探索——阻止常染色体显性多囊肾病的进展。
N Engl J Med. 2014 Dec 11;371(24):2329-31. doi: 10.1056/NEJMe1412586. Epub 2014 Nov 15.
9
Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中的高血压与左心室肥厚
Expert Rev Cardiovasc Ther. 2004 May;2(3):369-74. doi: 10.1586/14779072.2.3.369.
10
Cluster of differentiation 8 and programmed cell death ligand 1 expression in triple-negative breast cancer combined with autosomal dominant polycystic kidney disease and tuberous sclerosis complex: a case report.三阴性乳腺癌合并常染色体显性多囊肾病和结节性硬化症中分化簇8和程序性细胞死亡配体1的表达：一例报告
J Med Case Rep. 2019 Dec 24;13(1):381. doi: 10.1186/s13256-019-2274-6.
本文引用的文献
1
Foam Sclerotherapy for Cyst Volume Reduction in Autosomal Dominant Polycystic Kidney Disease: A Prospective Cohort Study.泡沫硬化疗法用于常染色体显性多囊肾病囊肿容积减小：一项前瞻性队列研究
Kidney Med. 2019 Oct 18;1(6):366-375. doi: 10.1016/j.xkme.2019.07.015. eCollection 2019 Nov-Dec.
2
Mutation Carriers Develop Kidney and Liver Cysts.突变携带者会出现肾和肝囊肿。
J Am Soc Nephrol. 2019 Nov;30(11):2091-2102. doi: 10.1681/ASN.2019030298. Epub 2019 Aug 8.
3
Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病中肾囊肿数量和体积的生长模式。
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):823-833. doi: 10.2215/CJN.10360818. Epub 2019 May 14.
4
Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model.托伐普坦治疗对常染色体显性多囊肾病肾功能下降的长期益处建模：使用常染色体显性多囊肾病结局模型的探索性分析
BMC Nephrol. 2019 Apr 23;20(1):136. doi: 10.1186/s12882-019-1290-5.
5
Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.兰瑞肽对常染色体显性多囊肾病患者肾功能的影响：DIPAK 1 随机临床试验。
JAMA. 2018 Nov 20;320(19):2010-2019. doi: 10.1001/jama.2018.15870.
6
Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease.Mcp1 促进常染色体显性多囊肾病中巨噬细胞依赖性囊肿扩张。
J Am Soc Nephrol. 2018 Oct;29(10):2471-2481. doi: 10.1681/ASN.2018050518. Epub 2018 Sep 12.
7
Are Cyst-Associated Macrophages in Polycystic Kidney Disease the Equivalent to TAMs in Cancer?多囊肾病中与囊肿相关的巨噬细胞等同于癌症中的肿瘤相关巨噬细胞吗？
J Am Soc Nephrol. 2018 Oct;29(10):2447-2448. doi: 10.1681/ASN.2018080846. Epub 2018 Sep 12.
8
Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.人群测序估算多囊肾病和多囊肝病的患病率。
J Am Soc Nephrol. 2018 Oct;29(10):2593-2600. doi: 10.1681/ASN.2018050493. Epub 2018 Aug 22.
9
Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.常染色体显性遗传多囊肾病患者肾功能下降的模式：HALT-PKD 试验的事后分析。
Am J Kidney Dis. 2018 May;71(5):666-676. doi: 10.1053/j.ajkd.2017.10.023. Epub 2018 Jan 3.
10
Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease.总肾体积是常染色体显性多囊肾病患者肾功能下降及进展至终末期肾病的预后生物标志物。
Kidney Int Rep. 2017 Jan 16;2(3):442-450. doi: 10.1016/j.ekir.2017.01.003. eCollection 2017 May.
Zotero 插件